Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib

Abstract Tyrosine kinase inhibitors represented by sorafenib are the first‐line treatment for hepatocellular carcinoma (HCC), but the low response rate of HCC patient has become a clinical pain‐point. Emerging evidences have revealed that metabolic reprogramming plays an important role in regulating...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Senlin Li, Lei Xu, Guo Wu, Ziqi Huang, Linzhuo Huang, Fengqian Zhang, Chunfang Wei, Qian Shen, Rong Li, Lei Zhang, Xiaoding Xu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-07-01
Colecção:	Advanced Science
Assuntos:	cofilin 1 hepatocellular carcinoma nanoparticles serine synthesis and metabolism sorafenib sensitivity
Acesso em linha:	https://doi.org/10.1002/advs.202207118
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!